Financial Incentives + Nurse Coaching for Type 2 Diabetes
(FINANCE-DM Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores whether adding financial rewards to nurse coaching and home monitoring can improve long-term control of Type 2 Diabetes (T2DM). Researchers aim to determine if these financial incentives make a difference and if their effects persist after the rewards end. Participants will be divided into two groups: one receiving nurse guidance, home monitoring, and financial incentives, and the other receiving only nurse guidance and home monitoring. Individuals who have struggled with T2DM management (defined by an A1c level of 8% or higher) and are comfortable using a home monitoring system might be a good fit. As an unphased trial, this study offers a unique opportunity to contribute to innovative diabetes management strategies.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It seems focused on financial incentives and nurse coaching rather than medication changes.
What prior data suggests that this protocol is safe for participants?
Research shows that the FINANCE-DM program, which includes nurse education, home health monitoring, and financial rewards, is safe and well-received by participants. Studies have examined the use of financial rewards in managing type 2 diabetes, and these have generally been safe.
Components of the FINANCE-DM program, such as nurse education and home monitoring, are widely used and have a strong safety record. Home monitoring allows participants to check their health from home, enabling timely adjustments without frequent clinic visits. This method has proven safe and effective for managing diabetes.
Overall, evidence suggests that the FINANCE-DM program is safe, with no serious side effects reported in related studies. Participants can feel confident about the safety of this approach when considering joining the trial.12345Why are researchers excited about this trial?
Researchers are excited about the FINANCE-DM intervention for Type 2 Diabetes because it combines nurse education, home telemonitoring, and structured financial incentives to encourage behavior change. Unlike traditional treatments that primarily focus on medication management, this approach integrates financial motivation and remote monitoring to boost patient engagement and adherence. The inclusion of financial incentives is particularly innovative, as it directly rewards patients for achieving health goals, potentially leading to better long-term outcomes.
What evidence suggests that this trial's treatments could be effective for Type 2 Diabetes?
Research has shown that combining financial rewards with other support can help people manage Type 2 diabetes more effectively. In this trial, participants in the FINANCE-DM intervention group, which included nurse guidance, home monitoring, and financial incentives, experienced a significant decrease in blood sugar levels, specifically a 1.30% reduction in A1C levels, an important measure of blood sugar control. This suggests that adding financial rewards to other support methods can be effective. Meanwhile, participants in the TIDES intervention group, which used mindfulness practices, also reduced stress and improved A1C levels. Both methods offer benefits, but combining financial incentives with coaching seems especially promising for long-term improvement.16789
Who Is on the Research Team?
Leonard Egede, MD
Principal Investigator
State University of New York at Buffalo
Are You a Good Fit for This Trial?
This trial is for adults over 21 with Type 2 Diabetes, specifically those who have not managed to control their blood sugar well (HbA1c >=8%). Participants must speak English, be willing to use a home monitoring system for a year, and have access to phone or internet. It's not open to those with life expectancies under 18 months, other diabetes trial participants, significant dementia, substance abuse issues, or acute mental disorders.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive nurse education, home telemonitoring, and structured financial incentives for 12 months
Sustainability Follow-up
Participants are monitored for sustainability of intervention effects after financial incentives are withdrawn
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- Active Comparator
- FINANCE-DM
Find a Clinic Near You
Who Is Running the Clinical Trial?
State University of New York at Buffalo
Lead Sponsor
Medical College of Wisconsin
Lead Sponsor